CAS 566161-24-8

N-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide

CAS : 566161-24-8

N-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2-fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide

Degré de pureté : 99%

Masse moléculaire : 487.58g/mol

Ref: 54-PC1007885

BMS-566419

CAS : 566161-24-8

BMS-566419: Acridinone-based IMPDH inhibitor for studying graft rejection.

Formule : C₂₈H₃₀FN₅O₂

Couleur et forme : Solid

Masse moléculaire : 487.57

Ref: TM-T63246

BMS 566419

CAS : 566161-24-8

BMS 566419 is a calcineurin inhibitor that has been approved for the treatment of multiple sclerosis. It is also used to prevent organ rejection in transplant patients who have received a new heart, kidney, or liver. BMS 566419 has been shown to inhibit the production of hydroxyproline and collagen by inhibiting the activity of inosine monophosphate dehydrogenase. This drug is taken orally and shows dose-dependent pharmacokinetic properties. The pharmacokinetic profile of this drug can be influenced by other drugs that are also metabolized by CYP3A4 enzymes (e.g., cyclosporin A).

Formule : C₂₈H₃₀FN₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 487.6 g/mol

Ref: 3D-RXA16124